Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study
暂无分享,去创建一个
K. Khunti | F. Zaccardi | N. Alwan | K. Pouwels | Sasha King | M. Glickman | V. Nafilyan | D. Ayoubkhani | M. Bosworth | A. Walker
[1] K. Bhaskaran,et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records , 2022, Nature Communications.
[2] C. Hastie,et al. Long Covid stigma: Estimating burden and validating scale in a UK-based sample , 2022, medRxiv.
[3] Z. Al-Aly,et al. Long Covid after Breakthrough COVID-19: the post-acute sequelae of breakthrough COVID-19 , 2021 .
[4] M. Taquet,et al. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections , 2021, Brain, Behavior, and Immunity.
[5] T. Peto,et al. The impact of SARS-CoV-2 vaccination on Alpha and Delta variant transmission , 2021, medRxiv.
[6] J. Farrar,et al. Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom , 2021, Nature Medicine.
[7] L. Smeeth,et al. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY , 2021, medRxiv.
[8] Ryan J. Low,et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact , 2020, EClinicalMedicine.
[9] P. Austin. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples , 2009, Statistics in medicine.